Publicaciones en las que colabora con MARÍA JOSEFA MONTERO GÓMEZ (30)

2021

  1. The antihypertensive and antihypertrophic effect of lycopene is not affected by and is independent of age

    Journal of Functional Foods, Vol. 85

2020

  1. Lycopene-supplemented diet ameliorates metabolic syndrome induced by fructose in rats

    Journal of Functional Foods, Vol. 73

2018

  1. Lycopene-supplemented diet ameliorates cardiovascular remodeling and oxidative stress in rats with hypertension induced by Angiotensin II

    Journal of Functional Foods, Vol. 47, pp. 279-287

2017

  1. Effects of milk casein hydrolyzate supplemented with phytosterols on hypertension and lipid profile in hypercholesterolemic hypertensive rats

    Journal of Functional Foods, Vol. 28, pp. 168-176

2016

  1. Peptide fragments from β-casein f(134–138), HLPLP, generated by the action of rat blood plasma peptidases show potent antihypertensive activity

    Food Research International, Vol. 88, pp. 348-353

  2. Zofenopril exerts a cardiovascular protective effect on rats infused with angiotensin II beyond angiotensin-converting enzyme inhibition

    Journal of Pharmacy and Pharmacology, Vol. 68, Núm. 11, pp. 1422-1429

2014

  1. Zofenopril evita las alteraciones cardiovasculares en ratones con infusión de Ang II

    Revista en Actualidad en Farmacología y Terapéutica

2013

  1. Licopeno previene la hipertensión y la hipertrofia cardiovascular producida por angiotensina

    Actualidad en farmacología y terapéutica, Vol. 11, Núm. 4, pp. 279-281

2012

  1. Acute effect of whey peptides upon blood pressure of hypertensive rats, and relationship with their angiotensin-converting enzyme inhibitory activity

    Molecular Nutrition and Food Research, Vol. 56, Núm. 2, pp. 316-324

2011

  1. Astaxanthin-enriched-diet reduces blood pressure and improves cardiovascular parameters in spontaneously hypertensive rats

    Pharmacological Research, Vol. 63, Núm. 1, pp. 44-50

  2. Long-term intake of a milk casein hydrolysate attenuates the development of hypertension and involves cardiovascular benefits

    Pharmacological Research, Vol. 63, Núm. 5, pp. 398-404

2009

  1. Cardiovascular changes in spontaneously hypertensive rats are improved by chronic treatment with zofenopril

    British Journal of Pharmacology, Vol. 158, Núm. 8, pp. 1911-1921

  2. Novel casein-derived peptides with antihypertensive activity

    International Dairy Journal, Vol. 19, Núm. 10, pp. 566-573

2005

  1. Astaxantina mejora la función endotelial, la estructura vascular y el estado redox en SHR: XXVII Congreso nacional de la SEF

    Actualidad en farmacología y terapéutica, Vol. 3, Núm. 4, pp. 301-302

2004

  1. Amlodipine decreases fibrosis and cardiac hypertrophy in spontaneously hypertensive rats: Persistent effects after withdrawal

    Life Sciences, Vol. 75, Núm. 7, pp. 881-891

2002

  1. Beneficial effects of trandolapril in uninephrectomized spontaneously hypertensive rats: Role of cyclooxygenase pathway

    Pharmacology and Toxicology, Vol. 91, Núm. 2, pp. 90-96

2000

  1. Mesenteric cyclooxygenase products after combined antihypertensive treatment in uninephrectomized SHRs

    Cardiovascular Drugs and Therapy, Vol. 14, Núm. 1, pp. 41-48

1999

  1. Antihypertensive effect of trandolapril and verapamil in rats with induced hypertension

    Journal of Cardiovascular Pharmacology, Vol. 33, Núm. 5, pp. 748-755

  2. Synthesis and inotropic activity of hydroindene derivatives

    Bioorganic and Medicinal Chemistry, Vol. 7, Núm. 12, pp. 2991-3001

1998

  1. Antihypertensive action of trandolapril and verapamil in spontaneously hypertensive rats after unilateral nephrectomy

    Journal of Cardiovascular Pharmacology, Vol. 32, Núm. 2, pp. 284-290